MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$13.59+0.05 (+0.37%)
Close on Nov 20, 2026Market cap $174.43MP/E –Yield –
MediWound free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$21.63M. The highest annual figure on record is $7.50M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.63M | – |
| FY2024 | Dec 31, 2024 | -$19.90M | – |
| FY2023 | Dec 31, 2023 | -$16.93M | – |
| FY2022 | Dec 31, 2022 | -$12.44M | – |
| FY2021 | Dec 31, 2021 | -$9.41M | – |
| FY2020 | Dec 31, 2020 | -$7.82M | -204.3% |
| FY2019 | Dec 31, 2019 | $7.50M | – |
| FY2018 | Dec 31, 2018 | -$12.68M | – |
| FY2017 | Dec 31, 2017 | -$17.50M | – |
| FY2016 | Dec 31, 2016 | -$17.12M | – |
| FY2015 | Dec 31, 2015 | -$19.98M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.20M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.81M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.32M | -137.0% |
| Q2 FY2022 | Jun 30, 2022 | -$5.39M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.01M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.92M | – |
| Q2 FY2019 | Jun 30, 2019 | $17.07M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.88M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.41M | – |
See a number that looks wrong?